HIV preexposure prophylaxis with tenofovir disoproxil fumarate/emtricitabine: What about safety in France?

被引：0
|
作者：
Ativon, F. [1 ]
Lebeller, C. [2 ]
Schiestel, T. [3 ]
Grandvuillemin, A. [4 ]
Davani, S. [1 ]
Valnet-Rabier, M. B. [1 ]
机构：
[1] Ctr Reg Pharmacovigilance Franche Comte, Besancon, France
[2] Ctr Reg Pharmacovigilance Paris, HEGP, Paris, France
[3] Ctr Reg Pharmacovigilance Paris Fernand Widal, Paris, France
[4] Ctr Reg Pharmacovigilance Bourgogne, Dijon, France
来源：
FUNDAMENTAL & CLINICAL PHARMACOLOGY | 2021年 / 35卷
关键词：
HIV PrEP; TDF/emtricitabine; safety;
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
PS-117
引用
收藏
页码：147 / 147
页数：1
相关论文
共 50 条
  • [1] HIV preexposure prophylaxis with tenofovir disoproxil fumarate/emtricitabine: What about safety?
    Jacomet, Carine
    Lebeller, Christine
    Schiestel, Thomas
    Grandvuillemin, Aurelie
    Davani, Siamak
    Valnet-Rabier, Marie-Blanche
    THERAPIE, 2022, 77 (06): : 635 - 647
  • [2] HIV Preexposure Prophylaxis With Emtricitabine and Tenofovir Disoproxil Fumarate Among Cisgender Women
    Marrazzo, Jeanne
    Tao, Li
    Becker, Marissa
    Leech, Ashley A.
    Taylor, Allan W.
    Ussery, Faith
    Kiragu, Michael
    Reza-Paul, Sushena
    Myers, Janet
    Bekker, Linda-Gail
    Yang, Juan
    Carter, Christoph
    de Boer, Melanie
    Das, Moupali
    Baeten, Jared M.
    Celum, Connie
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2024, 331 (11): : 930 - 937
  • [3] Safety of oral tenofovir disoproxil-emtricitabine for HIV preexposure prophylaxis in adults
    Liegeon, Geoffroy
    CURRENT OPINION IN HIV AND AIDS, 2022, 17 (04) : 199 - 204
  • [4] Metabolic Effects of Preexposure Prophylaxis With Coformulated Tenofovir Disoproxil Fumarate and Emtricitabine
    Glidden, David, V
    Mulligan, Kathleen
    McMahan, Vanessa
    Anderson, Peter L.
    Guanira, Juan
    Chariyalertsak, Suwat
    Buchbinder, Susan P.
    Bekker, Linda-Gail
    Schechter, Mauro
    Grinsztejn, Beatriz
    Grant, Robert M.
    CLINICAL INFECTIOUS DISEASES, 2018, 67 (03) : 411 - 419
  • [5] HIV preexposure prophylaxis with tenofovir disoproxil fumarate/emtricitabine and changes in kidney function and tubular health
    Ascher, Simon B.
    Scherzer, Rebecca
    Estrella, Michelle M.
    Shigenaga, Judy
    Spaulding, Kimberly A.
    Glidden, David V.
    Mehrotra, Megha L.
    Defechereux, Patricia
    Gandhi, Monica
    Grant, Robert M.
    Shlipak, Michael G.
    Jotwani, Vasantha
    AIDS, 2020, 34 (05) : 699 - 706
  • [6] Comparative Pricing of Branded Tenofovir Alafenamide-Emtricitabine Relative to Generic Tenofovir Disoproxil Fumarate-Emtricitabine for HIV Preexposure Prophylaxis
    Das, Moupali
    Ting, Jie
    Shreay, Sanatan
    Bush, Staci
    ANNALS OF INTERNAL MEDICINE, 2020, 173 (06) : 506 - 507
  • [7] Comparative Pricing of Branded Tenofovir Alafenamide-Emtricitabine Relative to Generic Tenofovir Disoproxil Fumarate-Emtricitabine for HIV Preexposure Prophylaxis
    Walensky, Rochelle P.
    Horn, Tim
    McCann, Nicole C.
    Freedberg, Kenneth A.
    Paltiel, A. David
    ANNALS OF INTERNAL MEDICINE, 2020, 172 (09) : 583 - +
  • [8] Inhibitory Effects of Probenecid on Pharmacokinetics of Tenofovir Disoproxil Fumarate and Emtricitabine for On-Demand HIV Preexposure Prophylaxis
    Liu, Stephanie N.
    Gufford, Brandon T.
    Lu, Jessica Bo Li
    Bushman, Lane R.
    Anderson, Peter L.
    Bergstrom, Richard F.
    Desta, Zeruesenay
    Gupta, Samir K.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2020, 107 (05) : 1200 - 1208
  • [9] Comparative Pricing of Branded Tenofovir Alafenamide-Emtricitabine Relative to Generic Tenofovir Disoproxil Fumarate-Emtricitabine for HIV Preexposure Prophylaxis RESPONSE
    Walensky, Rochelle P.
    Horn, Tim
    McCann, Nicole C.
    Freedberg, Kenneth A.
    Paltiel, A. David
    ANNALS OF INTERNAL MEDICINE, 2020, 173 (06) : 507 - +
  • [10] Urine assay for tenofovir to monitor adherence in real time to tenofovir disoproxil fumarate/emtricitabine as preexposure prophylaxis
    Koenig, H. C.
    Mounzer, K.
    Daughtridge, G. W.
    Sloan, C. E.
    Lalley-Chareczko, L.
    Moorthy, G. S.
    Conyngham, S. C.
    Zuppa, A. F.
    Montaner, L. J.
    Tebas, P.
    HIV MEDICINE, 2017, 18 (06) : 412 - 418
12345